4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-22-055368
Options or other derivatives
- Chief Operating Officer acquired 40,709 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Williams Paul Christopher Chief Operating Officer | 2022-10-31 | Grant or award · Stock option (right to buy) | +24,601 | 24,601 | D | ||
| Williams Paul Christopher Chief Operating Officer | 2022-10-31 | Grant or award · Restricted Stock Units | +16,108 | 16,108 | D | ||
Loading xslF345X03/doc4.xml…